Virginia Contract Research Organization Co., Ltd.
10
1
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Role: collaborator
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
Role: collaborator
A Study of GM-XANTHO in Pressure Ulcer Patients
Role: collaborator
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
Role: collaborator
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Role: collaborator
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis
Role: collaborator
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
Role: collaborator
To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC.
Role: collaborator
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers
Role: collaborator
Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis
Role: collaborator
All 10 trials loaded